Trial Treatment · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
The Ponce de Leon Center CRS Site# 5802, Atlanta · University of Colorado Hospital CRS (Site #6101), Aurora · Alabama CRS (Site # 31788), Birmingham · Massachusetts General Hospital CRS (MGH CRS) (Site #101), Boston · Chapel Hill CRS (Site #3201), Chapel Hill · Northwestern University CRS (Site # 2701), Chicago · Cincinnati Clinical Research Site (Site #2401), Cincinnati · Case Clinical Research Site (Site #2501), Cleveland · Ohio State University CRS (Site #2301), Columbus · Houston Advancing Research Team CRS (Site # 31473), Houston · University of California, Los Angeles CARE Center CRS (Site #601), Los Angeles · Vanderbilt Therapeutics (VT) CRS (Site #3652), Nashville · Columbia Physicians & Surgeons (P&S) CRS (Site #30329), New York · Penn Therapeutics CRS (Site #6201), Philadelphia · University of Pittsburgh CRS Site# 1001, Pittsburgh · University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site #31787), Rochester · UCSD Antiviral Research Center CRS (Site #701), San Diego · University of California, San Francisco HIV/AIDS CRS (Site #801), San Francisco · University of Washington Positive Research CRS (Site #1401), Seattle · Whitman-Walker Institute, Inc. CRS (Site #31791), Washington D.C.